George M Rodgers MD
Hematologic Oncology
Professor of Medicine, University Utah
Join to View Full Profile
1950 Circle Of Hope DrSalt Lake City, UT 84112
Phone+1 801-581-2121
Dr. Rodgers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1979 - 1982
Baylor College of MedicineResidency, Internal Medicine, 1976 - 1979
Tulane University School of MedicineClass of 1976
Certifications & Licensure
CA State Medical License 1978 - Present
UT State Medical License 1988 - 2026
FL State Medical License 2014 - 2022
LA State Medical License 1976 - 1987
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
American Board of Pathology Hematology
Clinical Trials
- A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Start of enrollment: 2014 Jul 14
Publications & Presentations
PubMed
- Reply to: Concerns on Potential Risk of Roxadustat in Promoting Tumor Progression: Double-Edged Sword of Hypoxia-Inducible Factor-1α Activation.George M Rodgers, Jeffrey A Gilreath
Journal of Clinical Oncology. 2025-04-01 - Development and validation of an algorithm to better identify pregnant women with inherited bleeding disorders within electronic health records.Ming Y Lim, Vasee Sivaloganathan, George M Rodgers, Sara E Simonsen
Thrombosis Research. 2025-02-01 - 2 citationsWill Prolyl Hydroxylase Inhibitors Supplant Erythropoiesis-Stimulating Agents and IV Iron in the Treatment of Chemotherapy-Induced Anemia?George M Rodgers, Jeffrey A Gilreath
Journal of Clinical Oncology. 2025-01-10
Abstracts/Posters
- Von Willebrand Disease Minimize Menorrhagia (VWDMin) TrialGeorge M. Rodgers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Pharmacoeconomic Analysis of Ideal Vs. Actual Body Weight-Based Treatment for Adult Persons with Hemophilia _Clinically Relevant AbstractGeorge M. Rodgers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
UCLA Jonsson Comprehensive Cancer Center Researchers at ASH 2021 Annual Meeting and ExpositionDecember 14th, 2021
(Epoetin Alfa-Epbx) Approved by U.S. FDAMay 15th, 2018
Grant Support
- Efficacy Of Enoxaparin In Trealment Of Deep Vein ThrombosisNational Center For Research Resources1995–1996
- Regulation Of Coagulation By Vascular CellsNational Heart, Lung, And Blood Institute1985–1986
- Nhlbi Clinical Investigator Award ProgramNational Heart, Lung, And Blood Institute1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
